Search Results - "MOORE, S. B"

A Comparison of Plasmapheresis Versus High‐Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody by Stegall, M.D., Gloor, J., Winters, J.L., Moore, S.B., DeGoey, S.

“…Several protocols allow for the successful transplantation of sensitized renal allograft recipients, yet no one best method has emerged. The aim of the current…”
Get full text

Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody by Gloor, J. M., Sethi, S., Stegall, M. D., Park, W. D., Moore, S. B., DeGoey, S., Griffin, M. D., Larson, T. S., Cosio, F. G.

“…Transplant glomerulopathy (TG) usually has been described as part of a constellation of late chronic histologic abnormalities associated with proteinuria and…”
Get full text

Kidney Transplantation in Patients with Antibodies against Donor HLA Class II by Pollinger, H. S., Stegall, M. D., Gloor, J. M., Moore, S. B., Degoey, S. R., Ploeger, N. A., Park, W. D., Pollinger, H. S., Stegall, M. D., Gloor, J. M., Moore, S. B., Degoey, S. R., Ploeger, N. A., Park, W. D.

“…The immunologic risk associated with donor‐specific antibodies (DSA) against Class II human leukocyte antigens (HLA) in kidney transplant (KTx) recipients is…”
Get full text

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma by PORRATA, L. F, GERTZ, M. A, LACY, M. Q, DISPENZIERI, A, SNOW, D. S, MARKOVIC, S. N, GEYER, S. M, LITZOW, M. R, GASTINEAU, D. A, MOORE, S. B, PINEDA, A. A, BUNDY, K. L, PADLEY, D. J, PERSKY, D

“…Absolute lymphocyte count at day 15 (ALC-15) after autologous peripheral blood hematopoietic stem cell transplantation (APHSCT) is an independent prognostic…”
Get full text

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma by PORRATA, L. F, LITZOW, M. R, MICALLEF, I. N. M, MARKOVIC, S. N, INWARDS, D. J, GASTINEAU, D. A, MOORE, S. B, PINEDA, A. A, BUNDY, K. L, PADLEY, D. J, PERSKY, D, ANSELL, S. M

“…Absolute lymphocyte count at day 15 (ALC-15) after autologous peripheral blood hematopoietic stem cell transplantation (APHSCT) is an independent prognostic…”
Get full text

Major histocompatibility complex class II alleles and the course and outcome of MS : A population-based study by WEINSHENKER, B. G, SANTRACH, P, BISSONET, A. S, MCDONNELL, S. K, SCHAID, D, MOORE, S. B, RODRIGUEZ, M

“…The major histocompatibility complex (MHC) has been consistently associated with susceptibility to MS and the course of several other human autoimmune…”
Get full text

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis by Strettell, MD, Donaldson, PT, Thomson, LJ, Santrach, PJ, Moore, SB, Czaja, AJ, Williams, R

“…BACKGROUND & AIMS: In a recent study, we suggested that susceptibility to type 1 autoimmune hepatitis is associated with a six-amino acid motif, LLEQKR, within…”
Get full text

Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations by Pittock, S J, Reindl, M, Achenbach, S, Berger, T, Bruck, W, Konig, F, Morales, Y, Lassmann, H, Bryant, S, Moore, S B, Keegan, B M, Lucchinetti, C F

“…Controversy exists regarding the pathogenic or predictive role of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with multiple sclerosis…”
Get full text

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis by Czaja, A J, Strettell, M D, Thomson, L J, Santrach, P J, Moore, S B, Donaldson, P T, Williams, R

“…Susceptibility for type 1 autoimmune hepatitis has been associated with the major histocompatibility alleles DRB1*0301, DRB3*0101, DRB1*0401, and DRB4*0103,…”
Get full text

Host- and disease-specific factors affecting steatosis in chronic hepatitis C by Czaja, Albert J., Carpenter, Herschel A., Santrach, Paula J., Breanndan Moore, S.

“…Background/Aim: Steatosis is commonly present in chronic hepatitis C. Our aim was to evaluate host- and disease-specific factors associated with its…”
Get full text

Children's levels of contingent self-esteem and social and emotional outcomes by Moore, Jonathan S. B., Smith, Marjorie

“…Contingent self-esteem (CSE) describes the degree to which self-esteem is dependent on meeting day-to-day appraisals from oneself and others. This will vary…”
Get full text

Plasma exchange conditioning for ABO-incompatible renal transplantation by Winters, J.L., Gloor, J.M., Pineda, A.A., Stegall, M.D., Moore, S.B.

“…The supply of deceased donor kidneys is inadequate to meet demand. To expand the pool of potential donors, ABO‐incompatible transplants from living donors have…”
Get full text

Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions by Pineda, A.A., Vamvakas, E.C., Gorden, L.D., Winters, J.L., Moore, S.B.

“…BACKGROUND: An increasing incidence of delayed hemolytic and delayed serologic transfusion reactions (DHTRs/DSTRs) has been seen at the Mayo Clinic since 1978…”
Get full text

Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target by KATIPAMULA, R, PORRATA, L. F, GASTINEAU, D. A, MARKOVIC, S. N, MOORE, S. B, GREINER, C, BURGSTALER, E. A, PADLEY, D. J, WINTERS, J. L

“…Autograft absolute lymphocyte count (A-ALC) is an independent prognostic factor for survival after autologous peripheral blood hematopoietic stem cell…”
Get full text

Diagnostic and pathogenetic considerations in transfusion-related acute lung injury by Popovsky, M A, Moore, S B

“…Transfusion-related acute lung injury (TRALI) is an infrequent but life-threatening complication of hemotherapy. The findings in 36 cases are described. The…”
Get more information

Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy by Popovsky, M A, Chaplin, Jr, H C, Moore, S B

Get more information

Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis by Vamvakas, E, Moore, S B

Get more information

Histologic Findings One Year After Positive Crossmatch or ABO Blood Group Incompatible Living Donor Kidney Transplantation by Gloor, J. M., Cosio, F. G., Rea, D. J., Wadei, H. M., Winters, J. L., Moore, S. B., DeGoey, S. R., Lager, D. J., Grande, J. P., Stegall, M. D.

“…Recent protocols have allowed successful positive crossmatch (+XM) and ABO incompatible (ABOI) kidney transplantation, although their long‐term outcome is not…”
Get full text

Ischemic-type biliary complications after orthotopic liver transplantation by Sanchez-Urdazpal, L, Gores, G J, Ward, E M, Maus, T P, Wahlstrom, H E, Moore, S B, Wiesner, R H, Krom, R A

“…Nonanastomotic biliary strictures that involve only the biliary tree of the graft occur after orthotopic liver transplantation in patients with hepatic artery…”
Get more information

Blood transfusion and postoperative septic complications by Vamvakas, E C, Moore, S B

Get more information